Diseases Home > Menveo Uses
Menveo helps prevent invasive meningococcal diseases such as bacterial meningitis. It works by "tricking" the body into thinking it has been exposed to the actual bacteria, but without the risks of a real infection. Although it is approved for people 2 months to 55 years of age, Menveo is used occasionally "off-label" to people outside of this age range.
What Is Menveo Used For?Menveo® (meningococcal vaccine) is a vaccine approved to provide protection against invasive meningococcal disease, including bacterial meningitis and bloodstream infections. Bacterial meningitis is a bacterial infection of the fluid surrounding the brain and spinal cord. Menveo provides protection only against meningococcal disease caused by Neisseria meningitidis; it does not provide protection against any other types of bacteria.
- Almost all children and adolescents between 11 and 18 years of age
- College freshmen living in dormitories
- Anyone living in or traveling to areas of the world where meningococcal disease is common
- Anyone with a damaged or removed spleen
- Laboratory workers who are routinely exposed to N. meningitidis
- United States military recruits
- People with a specific immune system disorder known as "terminal complement component deficiency"
- People who might have been exposed to meningitis during an outbreak.